Site Navigation
ASX & Press Releases
29/1/09 - Quarterly Report - Appendix 4C
29/1/09 - Director Appointment & Resignation
29/1/09 - Final Directors Interest Notice
29/1/09 - Initial Directors Interest Notice
1/12/08 - AGM Results
1/12/08 - AGM Presentation
1/12/08 - AGM Chairman’s speech
31/10/08 - Share Subscription Agreement Termination and Restriction Agreement Expiry
28/10/08 - Appendix 4C – Quarterly Report
28/10/08 - AGM Notice & Proxy Form
28/10/08 - Annual Report 08
23/10/08 - Chairman resignation
23/10/08 - Final Directors Interest Notice
1/9/08 - Appendix 4E Preliminary Final Report
5/8/08 - Change of Director’s Interest Notice
22/7/08 - Giaconda announces proposal for share placement
14/7/08 - Appendix 4C
View in Browser
9/7/08 - Giaconda Suspends Hepaconda® Phase II Trial to Carry Out Dose Ranging
20/6/08 - Appendix 3Y Moon
20/6/08 - Appendix 3Y Woods
20/6/08 - Appendix 3B
7/4/08 - Giaconda Receives European Patent for Myoconda®
11/3/08 - Half Year Report ended 31 Dec 2007
3/3/08 - Appendix 4D and Half Year Results
19/2/08 - Appendix 3Y (3)
19/2/08 - Appendix 3Y(2)
19/2/08 - Appendix 3Y (1)
19/2/08 - Appendix 3B
19/2/08 - Clinical Trial Pilot Results
8/2/08 -Giaconda has commenced next round of fundraising
29/1/08 - Appendix 4C
22/1/08 - Heliconda® Patent Granted
6/11/07 - Appendix 4C
29/10/07 - AGM Chairman's Spech
29/10/07 - AGM CEO's Spech
29/10/07 - AGM CMO's Presentation
24/9/07 - Clinical Trial Clarification
19/9/07 - Giaconda Signs Agreement to Take Myoconda® to Market in Europe
14/9/07 - Release of restricted securities from escrow on 27.09.07 and Appendix 3B
11/9/07 - 2007 Notice of AGM, Explanatory Memorandum and Proxy Form
11/9/07 - 2007 Annual Report
3/9/07 - Giaconda Appoints New Company Secretary
3/9/07 - Intersuisse analyst report on Giaconda Limited
28/8/07 - FY07 Appendix 4E Preliminary Final Report
27/8/07 - Hepaconda gains recognition as a promising drug
17/8/07 - Giaconda – office relocation and personnel change
23/7/07 - July 2007 Presentation – Company Update to Analysts
19/7/07 - Appendix 4C, Commitments Test Entity – Fourth Quarter Report
19/7/07 - Appendix 3B – Issue of Shares
19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (T. Moon)
19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (T. Moore)
19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (R. Woods)
18/7/07 - Australian study of anti-MAP treatment in Crohn’s Disease published showing highest ever remission rates
4/7/07 - Lapsed Employee Options
25/6/07 - Commencement of PhIIa clinical trial for Hepaconda® in Hepatitis C
7/5/07 - Giaconda appoints new COO
24/4/07 - FDA approves Myoconda® IND for MAP in Crohn’s Disease
18/4/07 - Commitments Test Entity – Third Quarter Report
4/4/07 - Appendix 3B (Issue of Shares)
4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moon)
4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moore)
4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (R. Woods)
View in browser
22/3/07 - Peer reviewed journal paper supports use of Giaconda’s lead product Myoconda® for Crohn’s Disease
19/2/07 - Appendix 3B (Issue of Shares)
19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moore)
19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moon)
19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (R. Woods)
13/2/07 - Half-Year FY07 Results
13/2/07 - Half-Year Report and Half-Year Accounts ended 31 Dec 2006
9/2/07 - Corporate Governance – amendment to contingent liabilities
18/1/07 - Commitments Test Entity – Second Quarter FY07
28/12/06 - Giaconda receives European patent for Ibaconda
22/12/06 - Clarification of Options issued by Giaconda
22/12/06 - Appendix 3B (Issue of Shares)
22/12/06 - Appendix 3X Initial Director’s Interest Notice (T. Moore)
22/12/06 - Appendix 3Y Change in Director's Interests Notice (A. Moon)
22/12/06 - Appendix 3Y Change in Director's Interests Notice (R. Woods)
19/12/06 - Newsletter Issue 2 – December 2006
9/11/06 - Giaconda receives European patent for Heliconda®
31/10/06 - Results of 2006 AGM
30/10/06 - Chairman’s Address at AGM to Shareholders
30/10/06 - CEO’s Speech at AGM
30/10/06 - CMO’s Presentation at AGM
24/10/06 - Giaconda announces Myoconda® poster presentation at American College of Gastroenterology meeting
19/10/06 - Commitments Test Entity – First Quarter FY07
18/10/06 - Giaconda announces positive Phase II data for Picoconda presented at AGW
17/10/06 - Giaconda signs non-binding letter of intent for Myoconda® active ingredient
28/9/06 - 2006 Annual Report
28/9/06 - Notice of 2006 AGM
26/9/06 - Giaconda signs non-binding letter of intent for Myoconda® commercialisation in Benelux territory
14/9/06 - Appendix 4E Preliminary Final Report
14/9/06 - Financial year ends with a positive outlook for 2007
24/8/2006 - Appendix 3Z - Final Director's Interest Notice
23/8/2006 - Giaconda appoints new Chairman
17/8/2006 - Appendix 3B - Issue of Options
01/08/2006 - Change of Director’s Interest Notice
01/08/2006 - Second Non-binding Loi for Commercialisation of Myoconda®
28/07/2006 - Commitments Test Entity – Fourth Quarter
28/07/2006 - Cessation/Appointment of Company Secretary
27/06/2006 - ASX Announcement of June 2006 Roadshow
19/05/2006 - Signs Service Agreement with CDD for Prof Borody
25/04/2006 - Commitments Test Entity - Third Quarter Report
13/04/2006 - Non-binding commercialisation LOI for Myoconda®® in UK
10/03/2006 - Newsletter Issue 1
10/03/2006 - Half Yearly Report and Half Year Accounts ended 31 Dec 2005
09/03/2006 - Hepaconda Patent Update
28/02/2006 - Amended initial Director's Interest Notice
06/02/2006 - Giaconda signs LOI with ICON for Myoconda® Phase IIIb study
06/02/2006 - Appendix 3B - Issue of options
31/01/2006 - Second Quarter Report
30/01/2006 - Heliconda Phase II study results published
18/01/2006 - Myoconda® Phase II study update
17/01/2006 - First Scientific Advisory Board Meeting held
21/12/2005 - Appointment of Asst Company Secretary & CAO
14/12/2005 - Giaconda meets FDA & MHRA supported by BioBusiness Grant
30/11/2005 - Holds First AGM
23/11/2005 - Supplement to Results of AGM
18/11/20005 - Results of AGM
13/10/2005 - AGM Notice 2005
13/10/2005 - Signed Full 2005 Accounts
06/10/2005 - Amended Initial Director's Interest Notice
05/10/2005 - Initial Director's Interest Notice x6
04/10/2005 - Nobel Prize Confirms Giaconda's Direction
26/09/2005 - Company Secretary Resignation/Appointment
23/09/2005 - Terms & conditions of options to Messrs Allen & Hare
23/09/2005 - Securities subject to escrow & voluntary escrow
23/09/2005 - Appendix 1A - ASX Listing application & agreement
23/09/2005 - Constitution
23/09/2005 - Audited accounts for year ended 30 June 2004
23/09/2005 - Audited accounts for year ended 30 June 2005
23/09/2005 - Updated Statement of Commitment
23/09/2005 - Top 20 shareholders
23/09/2005 - Distribution Schedule
23/09/2005 - Pre-Quotation Disclosure
23/09/2005 - ASX Circular: Commencement of Official Quotation
23/09/2005 - Admission to Official List
Home | Internet Legal Notice | Privacy Statement | Site Map
